Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States
β Scribed by C.-T. Wai; R. J. Fontana; J. Polson; M. Hussain; A. O. Shakil; S.-H. Han; T. J. Davern; W. M. Lee; A. S.-F Lok; The US Acute Liver Failure Study Group
- Book ID
- 108885747
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 66 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Important innovations, such as hepatitis B immune globulin (HBIG) and lamivudine, have been introduced to the care of patients undergoing liver transplantation (OLT) for viral hepatitis B (HBV) (over the last 15 years). We analyzed survival of OLT recipients with HBV in the United States to examine
Little information is available on acute liver failure (ALF) in the United States. We gathered demographic data retrospectively for a 2-year period from July 1994 to June 1996 on all cases of ALF from 13 hospitals (12 liver transplant centers). Data on the patients included age, hepatic coma grade o
Acute liver failure (ALF) is an uncommon but potentially lethal drug-related adverse effect that often leads to liver transplantation (LT) or death. A retrospective cohort study was performed with the United Network for Organ Sharing Standard Transplant Analysis and Research files. Recipients who un